R

Repare Therapeutics

D
RPTX
USD
-0.13
(-3.5912%)
Market Closed
3,192.00
Volume
-2.19
EPS
-
Div Yield
-2.141104
P/E
148,134,910.17
Market Cap
Today
-3.5912%
1 Week
4.179%
1 Month
0.867%
6 Months
6.402%
12 Months
-16.905%
Year To Date
-52.452%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ALDX
-0.06
(-1.1121%)
USD
A
ARCT
0.45
(2.4563%)
USD
A
ARWR
0.805
(3.9116%)
USD
A
ASND
-2.7
(-2.089%)
USD
B
BNTX
0.99
(0.9269%)
USD
B
BLUE
-0.0615
(-14.0764%)
USD
C
CRSP
1.15
(2.2656%)
USD
E
EDIT
-0.11
(-3.3537%)
USD

Title:
Repare Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
Do you need help or have a question?
Contact Us